PK Study of Gefurulimab SC in Healthy Chinese Adult Participants
Clinical trial NCT06677138 · COMPLETED
Trial details
- NCT number
- NCT06677138
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-28
- Primary completion
- 2025-03-19
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.